FDG-PET to predict different patterns of progression in multicentric glioblastoma: A case report

Journal of Neuro-Oncology

Volumn 90, Issue 1, 2008, Pages 47-51

  Colavolpe, Cécile ^a   Guedj, Eric ^a   Metellus, Philippe ^a   Barrie, Maryline ^a   Figarella Branger, Dominique ^a   Mundler, Olivier ^a   Chinot, Olivier ^a  

^a TIMONE HOSPITAL   (France)

Author keywords

Brain tumor; Fluorodeoxyglucose F18; Glioblastoma multiforme; Multicentric gliomas; Positron emission tomography

Indexed keywords

CARBOPLATIN; CARMUSTINE; CORTICOSTEROID; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; TEMOZOLOMIDE;

ADULT; ARTICLE; BRAIN METABOLISM; BRAIN NECROSIS; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CASE REPORT; COMPUTER SYSTEM; DRUG MEGADOSE; FRONTAL LOBE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; INTRACRANIAL HYPERTENSION; MALE; MULTIPLE CANCER; MULTIPLE CYCLE TREATMENT; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREDICTION; QUANTITATIVE ANALYSIS; RIGHT HEMISPHERE; TEMPORAL LOBE;

ADULT; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FLUORODEOXYGLUCOSE F18; GLIOBLASTOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROSURGICAL PROCEDURES; POSITRON-EMISSION TOMOGRAPHY;

EID: 50649095167     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-008-9629-y     Document Type: Article

References (21)

1. Batzdorf U, Malumid N (1963) The problem of multicentric gliomas. J Neurosurg 20:122-136
2. Graham DI, Lantos PL (2002) Greenfield's neuropathology, 7th edn. Arnold, London
3. Salvati M, Caroli E, Orlando ER, Frati A, Artizzu S, Ferrante L (2003) Multicentric glioma: Our experience in 25 patients and critical review of the literature. Neurosurg Rev 26:275-279
4. Jawahar A, Weilbaecher C, Shorter C et al (2003) Multicentric glioblastoma multiforme determined by positron emission tomography: A case report. Clin Neurol Neurosurg 106:38-40
5. Sato K, Kameyama M, Ishiwata K et al (1994) Multicentric glioma studied with positron emission tomography. Surg Neurol 42:14-18
6. Schifter T, Hoffman JM, Hanson MW et al (1993) Serial FDG-PET studies in the prediction of survival in patients with primary brain tumours. J Comput Assist Tomogr 17:509-561
7. Louis DN, Ohgaki H, Wiestler OD et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97-109
8. Ouafik L, Sauze S, Boudouresque F et al (2002) Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo. Am J Pathol 160:1279-1292
9. Stupp R, Mason WP, Van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996
10. Esteller M, Garcia-Foncillas J, Andion E et al (2000) Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 343:1350-1354
11. Pegg AE, Dolan ME, Moscghel RC (1995) Structure, function, and inhibition of O 6 -alkylguanine-DNA alkyltransferase. Prog Nucleic Acid Res Mol Biol 51:167-223
12. Hegi ME, Diserens AC, Gorlia T et al (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352:997-1003
13. Sharma MK, Mansur DB, Reifenberger G et al (2007) Distinct genetic signatures among pilocytic astrocytomas relate to their brain region origin. Cancer Res 67:890-900
14. Taylor MD, Poppleton H, Fuller C et al (2005) Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 8:323-335
15. Singh SK, Hawkins C, Clarke ID et al (2004) Identification of human brain tumour initiating cells. Nature 432:396-401
16. Vescovi AL, Galli R, Reynolds BA (2006) Brain tumour stem cells. Nat Rev Cancer 6:425-436
17. Zeppernick F, Ahmadi R, Campos B et al (2008) Stem cell marker CD133 affects clinical outcome in glioma patients. Clin Cancer Res 14:123-129
18. De Witte O, Lefranc F, Levivier M et al (2000) FDG-PET as a prognostic factor in high-grade astrocytoma. J Neurooncol 49:157-163
19. Padma MV, Said S, Jacobs M et al (2003) Prediction of pathology and survival by FDG PET in gliomas. J Neurooncol 64:227-237
20. Kato T, Aida T, Abe H et al (1990) Clinicopathological study of multiple gliomas - report of three cases. Neurol Med Chir (Tokyo) 30:604-609
21. Chadduck WM, Roycroft D, Brown MW (1983) Multicentric glioma as a cause of multiple cerebral lesions. Neurosurgery 13:170-175